Track KNSA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
KNSA - Kiniksa Pharmaceuticals Ltd (KNSA) has a earnings per share of $0.27, up 145.5% over the past year.
Latest EPS (Actual)
$0.27
Beat Rate
0.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | $0.32 | $0.27 | Miss | -16.67% |
| Feb 2026 | $0.40 | $0.17 | Miss | -57.50% |
| Oct 2025 | $0.37 | $0.23 | Miss | -37.84% |
| Jul 2025 | $0.26 | $0.23 | Miss | -11.54% |
| Apr 2025 | $0.28 | $0.11 | Miss | -60.71% |
| Feb 2025 | $0.02 | -$0.12 | Miss | -700.00% |
| Oct 2024 | $0.07 | -$0.18 | Miss | -357.14% |
| Jul 2024 | $0.01 | -$0.06 | Miss | -700.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.